Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease

Wilbert S. Aronow, Chul Ahn

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Use of β blockers in this study was associated with a 53% significant independent reduction in the incidence of new coronary events after controlling the confounding effects of other prognostic variables. The stepwise Cox regression model showed that significant independent predictors of new coronary events were age (risk ratio 1.03 for an increment of 1 year of age), cigarette smoking (risk ratio 1.9), systemic hypertension (risk ratio 2.0), diabetes mellitus (risk ratio 1.6), serum low-density lipoprotein cholesterol ≥125 mg/dl (risk ratio 1.6), serum high-density lipoprotein cholesterol ≤35 mg/dl (risk ratio 2.0), and use of β blockers (risk ratio 0.47).

Original languageEnglish (US)
Pages (from-to)1284-1286
Number of pages3
JournalAmerican Journal of Cardiology
Volume87
Issue number11
DOIs
StatePublished - Jun 1 2001

Fingerprint

Peripheral Arterial Disease
Odds Ratio
Myocardial Infarction
Incidence
Serum
Proportional Hazards Models
LDL Cholesterol
HDL Cholesterol
Diabetes Mellitus
Smoking
Hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{5789f40a738a443eaaf91551716333d6,
title = "Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease",
abstract = "Use of β blockers in this study was associated with a 53{\%} significant independent reduction in the incidence of new coronary events after controlling the confounding effects of other prognostic variables. The stepwise Cox regression model showed that significant independent predictors of new coronary events were age (risk ratio 1.03 for an increment of 1 year of age), cigarette smoking (risk ratio 1.9), systemic hypertension (risk ratio 2.0), diabetes mellitus (risk ratio 1.6), serum low-density lipoprotein cholesterol ≥125 mg/dl (risk ratio 1.6), serum high-density lipoprotein cholesterol ≤35 mg/dl (risk ratio 2.0), and use of β blockers (risk ratio 0.47).",
author = "Aronow, {Wilbert S.} and Chul Ahn",
year = "2001",
month = "6",
day = "1",
doi = "10.1016/S0002-9149(01)01521-1",
language = "English (US)",
volume = "87",
pages = "1284--1286",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease

AU - Aronow, Wilbert S.

AU - Ahn, Chul

PY - 2001/6/1

Y1 - 2001/6/1

N2 - Use of β blockers in this study was associated with a 53% significant independent reduction in the incidence of new coronary events after controlling the confounding effects of other prognostic variables. The stepwise Cox regression model showed that significant independent predictors of new coronary events were age (risk ratio 1.03 for an increment of 1 year of age), cigarette smoking (risk ratio 1.9), systemic hypertension (risk ratio 2.0), diabetes mellitus (risk ratio 1.6), serum low-density lipoprotein cholesterol ≥125 mg/dl (risk ratio 1.6), serum high-density lipoprotein cholesterol ≤35 mg/dl (risk ratio 2.0), and use of β blockers (risk ratio 0.47).

AB - Use of β blockers in this study was associated with a 53% significant independent reduction in the incidence of new coronary events after controlling the confounding effects of other prognostic variables. The stepwise Cox regression model showed that significant independent predictors of new coronary events were age (risk ratio 1.03 for an increment of 1 year of age), cigarette smoking (risk ratio 1.9), systemic hypertension (risk ratio 2.0), diabetes mellitus (risk ratio 1.6), serum low-density lipoprotein cholesterol ≥125 mg/dl (risk ratio 1.6), serum high-density lipoprotein cholesterol ≤35 mg/dl (risk ratio 2.0), and use of β blockers (risk ratio 0.47).

UR - http://www.scopus.com/inward/record.url?scp=0035371384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035371384&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(01)01521-1

DO - 10.1016/S0002-9149(01)01521-1

M3 - Article

C2 - 11377356

AN - SCOPUS:0035371384

VL - 87

SP - 1284

EP - 1286

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 11

ER -